An Open-label, Multi-center Controlled Clinical Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (AHUS)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 03 Nov 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

03 Nov 2023 Last checked against ClinicalTrials.gov record.
19 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
05 May 2014 The US FDA has approved Alexion Pharmaceuticals' supplemental Biologics License Application (sBLA) providing regular approval for eculizumab; regular approval includes data from this study.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com